{"filings":[{"id":177597,"accession_number":"0001096906-25-000287","cik":1763329,"company_name":"AIBOTICS, INC.","ticker":"AIBT","form_type":"8-K","filed_at":"2025-03-24T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Aibotics enters $165K software dev agreement for Philbot massage robot app","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Agreement with GMF Ventures LLC to develop iOS/Android apps for Philbot massage robot; total consideration $165,000.","First payment via 500,000 shares of common stock to Steve Fleurimont under Equity Incentive Plan.","Scope includes machine learning, computer vision, and robotic solutions; IP assigned to Aibotics as work-made-for-hire.","Development timeline spans 20–25 weeks through planning, design, backend, frontend, testing, and deployment phases.","Contract provides termination with 30-day notice and a $55,000 penalty for breach of prior notice."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210642,"accession_number":"0001096906-24-001786","cik":1763329,"company_name":"AIBOTICS, INC.","ticker":"AIBT","form_type":"8-K","filed_at":"2024-08-21T23:59:59+00:00","items":["1.01","5.03","9.01"],"status":"ready","headline":"Mycotopia exchanges 9.79M common shares for super voting preferred; Ehave gets 75% voting control","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Ehave Inc. exchanged 9,793,754 common shares (≈67% of outstanding) for 1,000 Series A Super Voting Preferred shares.","Series A Preferred holder controls 75% of total voting power; convertible back into 9,793,754 common shares.","Authorized common stock increased to 467,000,000 shares; amendment filed in Nevada on August 8, 2024.","Exchange Agreement executed July 29, 2024; Series A Preferred designation approved by board June 24, 2024.","Ehave is the largest shareholder; transaction consolidates voting control without change in economic ownership."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247613,"accession_number":"0001096906-24-000650","cik":1763329,"company_name":"AIBOTICS, INC.","ticker":"AIBT","form_type":"8-K","filed_at":"2024-03-28T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Mycotopia Therapies auditor changes: Pinnacle resigns, Fruci appointed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Pinnacle Accountancy Group resigned as independent auditor on March 21, 2024.","No disagreements or reportable events occurred during Pinnacle's engagement.","Fruci & Associates II, PLLC appointed as new independent registered public accounting firm effective March 21, 2024.","No prior consultations with Fruci on accounting principles or audit opinions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":265072,"accession_number":"0001096906-23-002316","cik":1763329,"company_name":"AIBOTICS, INC.","ticker":"AIBT","form_type":"8-K","filed_at":"2023-12-05T23:59:59+00:00","items":["1.01","2.01","3.02","7.01","9.01"],"status":"ready","headline":"Mycotopia Therapies acquires AI robotics assets from Philon Labs; up to $9M in stock, to rename AiBotics","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquires patents for Phill Robot (AI massage robot) and Milky Way (smart breast-milk fridge) from Philon Labs.","Issues $2M face-value convertible preferred stock; up to $7M more preferred stock tied to revenue incentives over 3 years.","Philon Labs CEO David Gruszka to become President of Mycotopia Therapies.","Company plans to change name to AiBotics and ticker to ABIT, pending FINRA approval.","Press release issued December 4, 2023 announcing the transaction."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":301427,"accession_number":"0001096906-23-000961","cik":1763329,"company_name":"AIBOTICS, INC.","ticker":"AIBT","form_type":"8-K","filed_at":"2023-05-03T23:59:59+00:00","items":["4.02"],"status":"ready","headline":"Mycotopia to restate 2022 financial statements; $288K cash comp and warrant to CEO omitted","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Unrecorded $288,000 cash compensation and a warrant for 5% of fully diluted shares granted to CEO.","Errors affect audited 2022 balance sheet/income statement and unaudited Q1–Q3 2022 interim reports.","Management cites insufficient accounting staff and lack of GAAP review as material control weaknesses.","Restated filings will include updated disclosures on these weaknesses and corrected financial data."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321241,"accession_number":"0001096906-23-000428","cik":1763329,"company_name":"AIBOTICS, INC.","ticker":"AIBT","form_type":"8-K","filed_at":"2023-02-22T23:59:59+00:00","items":["1.02","7.01","9.01"],"status":"ready","headline":"Mycotopia Therapies, PSLY.com, and Ei.Ventures mutually terminate merger agreement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Parties agreed to terminate the Agreement and Plan of Merger dated May 17, 2022 on February 16, 2023.","PSLY.com is withdrawing its Form S-4 Registration Statement and discontinuing its Nasdaq listing application.","CEO David Nikzad cited it was not the right time for the business combination or Nasdaq listing.","Mycotopia CEO Ben Kaplan noted overall market conditions were not favorable for creating optimal shareholder value."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":375177,"accession_number":"0001096906-22-001188","cik":1763329,"company_name":"AIBOTICS, INC.","ticker":"AIBT","form_type":"8-K","filed_at":"2022-05-19T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Mycotopia enters merger with Ei.Ventures under PSLY.com; total deal value ~$383M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Mycotopia shareholders to receive 0.25 PSLY.com share per TPIA share, valued at >$23M.","Ei.Ventures shareholders valued at $360M based on formula using $360M/$1.56 divided by 4x outstanding shares.","Transaction expected to close on or about July 30, 2022; companies plan NASDAQ uplisting.","Merger combines Ei's psilocybin products (Odyssey Elixir, Psilly patches) with Mycotopia's Jamaican and Dutch legal presence.","Combined entity PSLY.com to focus on natural remedies and metaverse expansion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":393556,"accession_number":"0001096906-22-000130","cik":1763329,"company_name":"AIBOTICS, INC.","ticker":"AIBT","form_type":"8-K","filed_at":"2022-01-14T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Mycotopia Therapies appoints Benjamin Kaplan as CEO; $24k/mo consulting fee, 5% equity warrants","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO appointment effective Jan 19, 2021; initial 36-month term with automatic 12-month renewal.","Monthly consulting fee of $24,000; expense allowance of $7,000 per month; disability insurance provided.","Equity compensation includes warrants for 5% of fully diluted shares as bonus milestones and a 5% stock grant on significant transactions.","Termination without cause triggers a severance equal to three years of total compensation (fees, bonuses, equity grants, insurance).","Agreement includes standard non-compete, non-solicitation, and confidentiality covenants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}